These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11085500)

  • 1. SPIO-MRI in the detection of hepatocellular carcinoma.
    Araki T
    J Gastroenterol; 2000; 35(11):874-6. PubMed ID: 11085500
    [No Abstract]   [Full Text] [Related]  

  • 2. MR enhancement of hepatoma by superparamagnetic iron oxide (SPIO) particles.
    Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Takahashi M
    J Comput Assist Tomogr; 1995; 19(4):665-7. PubMed ID: 7622710
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor-detecting capacity and clinical usefulness of SPIO-MRI in patients with hepatocellular carcinoma.
    Nakamura H; Ito N; Kotake F; Mizokami Y; Matsuoka T
    J Gastroenterol; 2000; 35(11):849-55. PubMed ID: 11085494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of liver lesions: magnetic resonance tomography using superparamagnetic iron particles (AMI-25, endorem) as a contrast medium in comparison with ultrasound diagnosis, computerized tomography and CT portography].
    Pleger B; Beyer HK; Laufer U
    Rontgenpraxis; 2001; 53(6):245-9. PubMed ID: 11402872
    [No Abstract]   [Full Text] [Related]  

  • 5. Resovist for imaging of hepatocellular carcinoma in the cirrhotic liver.
    Weishaupt D; Willmann JK; Lutz AM; Marincek B
    Eur Radiol; 2004 Jan; 14 Suppl 1():C5-6. PubMed ID: 15113059
    [No Abstract]   [Full Text] [Related]  

  • 6. Double contrast MR imaging of hepatocellular carcinoma evaluating lesion detection and conspicuity.
    Akinci D; Oto A; Besim A; Akhan O; Abbasoglu O; Batman F; Eryilmaz M
    Acad Radiol; 2002 Aug; 9 Suppl 2():S466-7. PubMed ID: 12188310
    [No Abstract]   [Full Text] [Related]  

  • 7. European clinical experience with Endorem. A new contrast agent for liver MRI in 1000 patients.
    Chachuat A; Bonnemain B
    Radiologe; 1995 Nov; 35(11 Suppl 2):S274-6. PubMed ID: 8588035
    [No Abstract]   [Full Text] [Related]  

  • 8. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images.
    Inoue T; Kudo M; Hatanaka K; Takahashi S; Kitai S; Ueda T; Ishikawa E; Hagiwara S; Minami Y; Chung H; Ueshima K; Maekawa K
    Oncology; 2008; 75 Suppl 1():48-54. PubMed ID: 19092272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Obsolete methods in examination of the liver with MRI].
    Schadmand-Fischer S
    Rofo; 1998 Dec; 169(6):679-80. PubMed ID: 9930229
    [No Abstract]   [Full Text] [Related]  

  • 10. [MR contrast agent: resovist (SH U 555A)].
    Nakajima H; Ichikawa T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():328-32. PubMed ID: 11761967
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging.
    Saini S; Edelman RR; Li W; Petersein J; Hahn PF
    Acad Radiol; 1996 Aug; 3 Suppl 2():S409-12. PubMed ID: 8796616
    [No Abstract]   [Full Text] [Related]  

  • 12. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
    Kim YK; Kim CS; Kwak HS; Lee JM
    J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical usefulness of SPIO-MRI in detection and staging of hepatocellular carcinoma].
    Koh KC; Kim HJ; Choe WH; Chae GS; Choi MS; Lee JH; Paik SW; Rhee JC; Choi KW
    Taehan Kan Hakhoe Chi; 2003 Mar; 9(1):17-24. PubMed ID: 12657825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma.
    Tanimoto A; Kuribayashi S
    Eur J Radiol; 2006 May; 58(2):200-16. PubMed ID: 16414230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI in focal liver disease: a comparison of small and ultra-small superparamagnetic iron oxide as hepatic contrast agents.
    Mergo PJ; Engelken JD; Helmberger T; Ros PR
    J Magn Reson Imaging; 1998; 8(5):1073-8. PubMed ID: 9786144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging.
    Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Hatanaka Y; Murakami R; Nishiharu T; Takahashi M; Higashida Y; Moribe N
    Radiology; 1995 Apr; 195(1):106-12. PubMed ID: 7892448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced MRI of focal liver lesions: differentiation and detection of primary and secondary liver lesions using Resovist-enhanced versus gadolinium-enhanced MRI in the same patient.
    Hammerstingl R; Vogl TJ; Schwarz W; Kümmel S; Balzer T; Neuhaus P; Felix R
    Acad Radiol; 1998 Apr; 5 Suppl 1():S75-9; discussion S93-4. PubMed ID: 9561049
    [No Abstract]   [Full Text] [Related]  

  • 18. Results of a multicenter phase II clinical trial with a susceptibility contrast medium for magnetic resonance imaging of the liver.
    Balzer T; Carter EC; Shamsi K; Niendorf HP
    Acad Radiol; 1996 Aug; 3 Suppl 2():S417-9. PubMed ID: 8796619
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the diagnostic efficacy of SPIO enhanced MRI in patients with focal hepatic lesions--comparison with CECT and CTAP].
    Kasugai H; Katayama N; Sakai S; Yamakawa T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2311-5. PubMed ID: 12484062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.